Locations:
Search IconSearch

Mobile Stroke Unit Trims Treatment Times (Video)

Bringing stroke treatment directly to the patient when every minute matters

15-CCC-143 SOTC Hero Image 690x380pxl

Cleveland Clinic has launched Mobile Stroke Treatment Unit (MSTU) with its own lab, CT scanner, and specially trained personnel, to diagnose and begin treatment of potential stroke patients at the scene and on their way to the hospital. The team from the Cerebrovascular Center, directed by Peter Rasmussen, MD, is among the first in American to have an MTSU, and they have improved the concept with innovations, including the use of telemedicine to allow neurologists to manage patients remotely. “The MSTU essentially brings the emergency room to the patient,” says Dr. Rasmussen. So far, the MSTU has enabled caregivers to treat patients with thrombolytic therapy within a mean of 19 minutes of getting into the mobile unit – well below the 60 minute window recommended by guidelines. The MSU is projected to save between $2-4 million in its first year through savings in post-acute stroke therapy.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad